2-pyridinecarbaldehyde 2-quinolylhydrazone | 190437-40-2

• 物质功能分类: 化学试剂 - 有机试剂 - 腙
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-pyridinecarbaldehyde 2-quinolylhydrazone
• 英文别名: N-Pyridin-2-ylmethylene-N'-quinolin-2-yl-hydrazine；Pyridine-2-carboxaldehyde 2-quinolylhydrazone；N-[(E)-pyridin-2-ylmethylideneamino]quinolin-2-amine
• CAS: 190437-40-2；7385-99-1
• 化学式: C₁₅H₁₂N₄
• 分子量: 248.287
• InChiKey: RQKUHYQNHJJIFO-GZTJUZNOSA-N

物化性质

• 熔点：
  203-206°C
• 沸点：
  459.8±33.0 °C(Predicted)
• 密度：
  1.19±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  19
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-pyridinecarbaldehyde 2-quinolylhydrazone 、 N-苯基马来酰亚胺 、 邻二甲苯 以24%的产率得到
  参考文献：
  名称：

  GRIGG, RONALD;DOWLING, MARIE;JORDAN, MAURICE W.;SRIDHARAN, VISUVANATHAR;T+, TETRAHEDRON, 43,(1987) N 24, 5873-5886

  摘要：

  DOI：
• 作为产物：
  描述：

  2-肼喹啉 、 吡啶-2-甲醛 以 乙醇 为溶剂， 反应 1.0h， 生成 2-pyridinecarbaldehyde 2-quinolylhydrazone
  参考文献：
  名称：

  Pellerano; Savini; Massarelli, Farmaco, Edizione Scientifica, 1985, vol. 40, # 9, p. 645 - 654

  摘要：

  DOI：

文献信息

• Theramutein modulators
  申请人：Housey Gerad M.

  公开号：US20100016298A1

  公开（公告）日：2010-01-21

  This invention relates to agents that are inhibitors or activators of variant forms of endogenous proteins and novel methods of identifying such variants. Of particular interest are inhibitors and activators of endogenous protein variants, encoded by genes which have mutated, which variants often arise or are at least first identified as having arisen following exposure to a chemical agent which is known to be an inhibitor or activator of the corresponding unmutated endogenous protein.

  这项发明涉及的是抑制或激活内源性蛋白变异形式的试剂以及识别这些变异的新方法。特别感兴趣的是那些由突变基因编码的内源性蛋白变异的抑制剂和激活剂，这些变异通常是在暴露于已知是相应未突变内源性蛋白的抑制剂或激活剂的化学试剂之后出现，或者至少是首次被识别为由此类化学试剂引起的。
• Medicinal uses of hydrazones
  申请人：The Procter & Gamble Company

  公开号：US20030092716A1

  公开（公告）日：2003-05-15

  Compounds having a structure according to Formula (I): 1 are effective in a method of increasing erythropoietin and vascularization of tissue in a subject in need thereof.

  具有如下式（I）所示结构的化合物在增加促红细胞生成素和血管化组织的方法中对需要的受试者有效。
• Novel hydrazone-based and oxime-based fluorescent and chromophoric/pro-fluorescent and pro-chromophoric reagents and linkers
  申请人：Schwartz David A.

  公开号：US20080221343A1

  公开（公告）日：2008-09-11

  Conjugationally extended hydrazine compositions of the formula (RR 2 )N(H) n (NH 2 ) n , fluorescent hydrazone compositions of the formula (RR 2 )NN═C(R 1 R 2 ), methods of the formation of hydrazones from the reaction of conjugationally extended hydrazines with conjugationally extended carbonyls and methods of their use in assays systems are described. Use of these conjugationally extended hydrazine and oxime compositions for direct calorimetric and fluorometric assays wherein a chromophore or the fluorophore is incorporated into the linker that is positioned between a reactive linking moiety and a biotin molecule. More specifically the linker comprises one molecule of a high affinity binding pair such as for example biotin of the biotin/avidin high affinity binding pair, connected to a spacer molecule such as for example a length of polyethyleneglycol followed by a pro-chromophoric, chromophoric, pro-fluorescent or fluorescent moiety connected to an amino-, thiol- or carbohydrate-reactive moiety such as for example succinimidyl, maleimido or aminoxy group respectively, that may covalently link to a biomolecule.

  描述了公式(RR2)N(H)n(NH2)n的共轭扩展肼组合物，公式(RR2)NN═C(R1R2)的荧光肼酮组合物，以及从共轭扩展肼与共轭扩展羰基化合物反应形成肼酮的方法，以及在测定系统中使用它们的方法。利用这些共轭扩展肼和肟组合物进行直接量热和荧光测定，其中色团或荧光团被并入连接基团中，该连接基团位于反应性连接基团和生物素分子之间。更具体地，连接基团包括一分子高亲和性结合对之一，例如生物素/亲和素高亲和性结合对之一，连接到一个间隔分子，例如一段聚乙二醇长度，后接一个前色团、色团、前荧光团或荧光团，连接到一个氨基、硫醇或碳水化合物反应性基团，例如琥珀酰亚胺基、马来酰亚胺基或氨氧基团，可以共价连接到生物分子。
• Enhancers of Protein Degradation
  申请人：Wanker Erich

  公开号：US20120282629A1

  公开（公告）日：2012-11-08

  The present invention relates to compounds suitable for modulating huntingtin protein processing and useful for treating or preventing huntingtin-related disorders. The invention provides pharmaceutical compositions comprising said compounds and methods of syntheses thereof.

  本发明涉及适用于调节亨廷顿蛋白处理并用于治疗或预防亨廷顿相关疾病的化合物。本发明提供了包含所述化合物的药物组合物以及其合成方法。
• N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION
  申请人：Aktas Bertal Huseyin

  公开号：US20120115915A1

  公开（公告）日：2012-05-10

  Compositions and methods for inhibiting translation initiation are provided. Compositions, methods and kits for treating (1) cellular proliferative disorders, (2) non-proliferative, degenerative disorders, (3) viral infections, and/or (4) disorders associated with viral infections, using N,N′-diarylureas and/or N,N′-diarylthiourea compounds are described.

  本文提供了抑制翻译起始的组合物和方法。描述了使用N，N'-二芳基脲和/或N，N'-二芳基硫脲化合物治疗（1）细胞增生性疾病，（2）非增生性退行性疾病，（3）病毒感染和/或（4）与病毒感染相关的疾病的组合物、方法和试剂盒。

表征谱图